Fund Holdings — PFIZER INC

Total Portfolio Value:
$236.46M
Total Bought:
$0
Total Sold:
$224.72M
Net Transaction:
-$224.72M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ORIC Pharmaceuticals, Inc.(ORIC)5,376,3445,376,3440$64.52M$43.98M18.60%-$20.54M
Arvinas, Inc.(ARVN)3,457,8153,457,8150$29.46M$41.01M17.34%+$11.55M
Celcuity Inc.(CELC)349,406349,4060$17.26M$34.85M14.74%+$17.59M
Wave Life Sciences, Inc.SHS(WVE)1,875,0001,875,0000$13.72M$31.88M13.48%+$18.15M
Allogene Therapeutics Inc22,032,04022,032,0400$27.32M$30.18M12.76%+$2.86M
Zura Bio LimitedCL A(ZURA)2,970,0222,970,0220$12.86M$15.56M6.58%+$2.70M
Pyxis Oncology, Inc.(PYXS)7,032,7707,032,7700$15.61M$8.09M3.42%-$7.53M
Caribou Biosciences, Inc.(CRBU)4,690,4314,690,4310$10.93M$7.46M3.15%-$3.47M
Cardiff Oncology, Inc.(CRDF)2,411,5752,411,5750$4.97M$6.78M2.87%+$1.81M
Biohaven Ltd.(BHVN)505,645505,6450$7.59M$5.71M2.41%-$1.88M
Spero Therapeutics, Inc.(SPRO)2,362,3482,362,3480$4.44M$5.50M2.33%+$1.06M
Nextcure Inc157,646157,6460$923.8K$2.24M0.95%+$1.31M
Zentalis Pharmaceuticals, Inc.(ZNTL)953,834953,8340$1.44M$1.29M0.54%-$152.6K
Q32 Bio Inc.(QTTB)277,777277,7770$550.0K$922.2K0.39%+$372.2K
An2 Therapeutics Inc715,295715,2950$908.4K$815.4K0.34%-$93.0K
Bolt Biotherapeutics Inc31,30531,3050$166.5K$171.2K0.07%+$4.6K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)2,9282,9280$42.7K$24.3K0.01%-$18.4K
Senseonics Holdings, Inc.(SENS)43,4262,171-41,255$18.9K$12.0K0.01%-$7.0K
BioNTech SEADS(BNTX)1,658,3610-1,658,361$163.55M$0—-$163.55M
Essa Pharma Inc1,675,0000-1,675,000$319.9K$0—-$319.9K
Tourmaline Bio Inc1,272,2140-1,272,214$60.85M$0—-$60.85M
Page 1 of 1
PFIZER INC — 13F Holdings — Q4 2025 | TickerTrail